Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Trends & Forecasts

The Battle for the Future of American Healthcare

| James Strachan

Both candidates for the US presidency are advocating policies that would create a new pricing environment for pharma companies – but we’ve been here before. With regard to the Affordable Care Act, however, the election could prove a real turning point.

Business & Regulation Business Practice

Harnessing Dark Data

| Graeme Dennis

The pharma industry creates significant amounts of data – so why is most of it hoarded and never made accessible?

Business & Regulation Business Practice

Crisis Point

| Maryam Mahdi

The COVID-19 pandemic has caused worldwide disruption, but how has the it affected African pharma?

Register to personalize your newsfeed

Create Account

Latest Articles

 Business & Regulation Quality & Compliance

A Brave New World of Quality

| David Jones

QC must evolve to meet progress in biopharmaceutical manufacturing.
Business & Regulation Business Practice

Stemming the Brain Drain

| Kelly Chibale

What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?
Business & Regulation Business Practice

Why the African Medicines Agency’s Hour Has Arrived

| Sarah Adam, Cyntia Genolet

Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?
Manufacture Advanced Medicine

Serving a Rising Power

| Sponsored by GenScript

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?
Manufacture Vaccines

Success at Speed Part 6: Logistics and Global Availability

| Piergiuseppe Nestola, Amélie Boulais

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Manufacture Advanced Medicine

A Living Elixir?

| James Strachan

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.
Manufacture Vaccines

Success at Speed Part 5: Reducing Costs

| Amélie Boulais, Piergiuseppe Nestola

Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price.
Business & Regulation Business Practice

Brexit Trading Unknowns

| Nik Kotecha

Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.
Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Sutton

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.
Manufacture Technology and Equipment

Top Tier Innovation

Nominate the top pharmaceutical technologies in our 2020 Innovation Awards.
All Articles

Upcoming Events

-

Extractables and Leachables USA 2020

Bethesda, MD, USA

Smithers’ 9th annual Extractables and Leachables USA conference is returning to Bethesda, MD,  October 26-28, 2020. This...

Cell & Gene Therapy USA

Virtual event

Join 2000+ cell and gene commercial leaders for this free conference and get treatments to patients faster.
-

2020 ISPE Annual Meeting & Expo: Driving the Future of Pharma

Virtual event

The 2020 #ISPE Annual Meeting & Expo is an immersive interactive event for the global pharma community. Join your...
Event
-

Extractables and Leachables USA 2020

Bethesda, MD, USA

Smithers’ 9th annual Extractables and Leachables USA conference is returning to Bethesda, MD,  October 26-28, 2020. This is a unique event in the extractables and leachables industry, bringing together top companies from the entire supply chain; making it easy to network with peers, and leading to new, beneficial connections.

More information

Event

Cell & Gene Therapy USA

Virtual event

Join 2000+ cell and gene commercial leaders for this free conference and get treatments to patients faster.

More information

Event
-

2020 ISPE Annual Meeting & Expo: Driving the Future of Pharma

Virtual event

The 2020 #ISPE Annual Meeting & Expo is an immersive interactive event for the global pharma community. Join your colleagues worldwide as we come together for 60+ hours of thought-provoking sessions led by leading experts from ANSM, FDA, Kite Pharma, GSK, Health Canada, MHRA, WHO, Vetter Pharma, and more!

More information

All Events

Sister Publications

You might be interested in our Sister Publications:

Latest White Papers

Simple and Effective Method for Purification of DMT-ON Oligonucleotides using HIC Resins

| Contributed by Tosoh

Characterization of Recombinant Protein Biotherapeutics by UHPLC-SEC-MALS

| Contributed by Tosoh

Confident peptide mapping and disulfide bond analysis of an IgG2 monoclonal antibody

| Contributed by Thermo Fisher Scientific

HPLC Column for quick Evaluation of ADCC Activity

| Contributed by Tosoh

All White Papers

Webinars on Demand

Manufacture Advanced Medicine

Advanced logistics for advanced therapies: Evidence using VIA Capsule™ cryogenic system

| Sponsored by Cytiva

Cell therapy logistics is challenged by complex processes, inefficiency, and lack of flexibility to accommodate manufacturing, clinic, and patient needs
Manufacture Bioprocessing - Upstream & Downstream

Simplicity and robust control with the Erbi Breez ™ True Perfusion™ microfluidic bioreactor system

| Sponsored by Erbi Biosystems

Upstream process intensification efforts are becoming mainstream in every biopharma R&D lab and clinical program.
Manufacture Standards & Regulation

Practical Management of Pharmaceutical Impurities

| Sponsored by Hovione

With this webinar we pretend to look at the different sorts of impurities that may occur in pharmaceutical products and discuss current regulations, requirements and control strategies to be followed in order to comply with the current demands.
All Webinars

Most popular articles

1. Manufacture Advanced Medicine

A Living Elixir?

| James Strachan

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.
2. Discovery & Development Drug Delivery

Melt in the Mouth

| Elizabeth Hickman

Orally dissolving tablets could be a good match for patients that dislike swallowing tablets.
3.

Cartoons

Trials of a Medicine Maker
4. Discovery & Development Clinical Trials

A Matter of Trust

| Maryam Mahdi

Can we trust the integrity of clinical trials?
5. Discovery & Development Drug Delivery

Dosing For Compliance

| Sven Stegemann

Are current dosage forms really as easy and convenient for patients as pharma manufacturers say they are?

Discovery & Development

Drug Delivery

The Long and Short of It

| Robert W. Lee

Why drug developers should take a fresh look at long-acting dosage forms.
Drug Discovery

Does AI Dream of Electric Patents?

| Amy Nick

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.
Clinical Trials

A Matter of Trust

| Maryam Mahdi

Can we trust the integrity of clinical trials?

Manufacture

Advanced Medicine

Serving a Rising Power

| Sponsored by GenScript

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?
Vaccines

Success at Speed Part 6: Logistics and Global Availability

| Piergiuseppe Nestola, Amélie Boulais

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Advanced Medicine

A Living Elixir?

| James Strachan

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.

Business & Regulation

Quality & Compliance

A Brave New World of Quality

| David Jones

QC must evolve to meet progress in biopharmaceutical manufacturing.
Trends & Forecasts

The Battle for the Future of American Healthcare

| James Strachan

Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.
Business Practice

Harnessing Dark Data

| Graeme Dennis

Graeme Dennis questions why the industry refuses to make use of the significant amount of data it generates.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker